Cargando…
Biological and molecular studies on specific immune cells treated with checkpoint inhibitors for the thera-personal approach of breast cancer patients (ex-vivo study)
Immunotherapy becomes a promising line of treatment for breast cancer (BC) however, its success rate is still limited. METHODS: The study was designed to optimize the condition for producing an effective dendritic cell (DCs) based immunotherapy by using DCs and T lymphocytes together with tumor-infi...
Autores principales: | EL-HOUSEINI, MOTAWA E., ARAFAT, MOSTAFA S., EL-HUSSEINY, AHMED M., KASEM, ISLAM M., KAMEL, MAHMOUD M., EL-HABASHY, AHMED H., KHAFAGY, MEDHAT M., RADWAN, ENAS M., HELAL, MAHA H., ABDELLATEIF, MONA S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tech Science Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207991/ https://www.ncbi.nlm.nih.gov/pubmed/37305162 http://dx.doi.org/10.32604/or.2022.025249 |
Ejemplares similares
-
Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects
por: Afifi, Ahmed M, et al.
Publicado: (2019) -
The potential immuno-stimulating effect of curcumin, piperine, and taurine combination in hepatocellular carcinoma; a pilot study
por: kotb, Raghda R., et al.
Publicado: (2023) -
Possible Use of miR-223-3p as a Prognostic Marker in Transarterial Chemoembolization Treatment of Hepatocellular Carcinoma Patients
por: Abdelaziz, Heba E., et al.
Publicado: (2022) -
Novel protective role of curcumin and taurine combination against experimental hepatocarcinogenesis
por: El-Houseini, Motawa Eisa, et al.
Publicado: (2017) -
The role of inflammatory indices in the outcome of COVID-19 cancer patients
por: Nooh, Hend A., et al.
Publicado: (2021)